Atkore has seen a 21% run-up since we initiated BUY coverage on the stock in March 2023. Atkore’s valuation is still reasonable and there is still some upside. Our longer-term thesis remains intact.

Onsemi's share price dropped 20% after reporting lower guidance, presenting a buying opportunity for long-term investors. Q3 sales were slightly above estimates, with strong growth in the automotive ...

We maintain our fair value estimate of HKD 64 for JD Health 06618 after the company reported second-half revenue of CNY 26.5 billion, which was better than the top range of guidance of CNY 23.9 ...

We expect to maintain our $42 fair value estimate for narrow-moat Chewy CHWY as we mull over quarterly results, with sluggish active customer growth (we’re lowering our annual forecast to 1.3% growth ...

Pembina Pipeline runs on long-term, fee-based contracts, producing predictable cash flow ...

How much frailty in old age can shorten life apparently depends on how long a dog’s hormonal balance remains intact. A study of exceptionally long-lived Rottweilers shows: In males that were neutered ...